Bristlecone Advisors, LLC Abb Vie Inc. Transaction History

Bristlecone Advisors, LLC

$1.24 Billion
Q3 2024

A detailed history of Bristlecone Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 1,515 shares of ABBV stock, worth $272,700. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,515

Previous 1,801 15.88%

Holding current value

$272,700

Previous $308,000 2.92%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $46,858 - $57,008	-286 Reduced 15.88%	1,515 $299,000
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $18,574 - $21,691	-120 Reduced 6.25%	1,801 $308,000
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $24,905 - $28,049	181 Added 10.4%	1,921 $297,000
Q3 2023 Oct 16, 2023	SELL	$133.59 - $154.65 $1,068 - $1,237	-8 Reduced 0.46%	1,740 $259,000
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $530 - $659	4 Added 0.23%	1,748 $235,000
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $38,610 - $44,466	-267 Reduced 13.28%	1,744 $277,000
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $52,834 - $63,362	-382 Reduced 15.96%	2,011 $325,000
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $6,307 - $7,234	-47 Reduced 1.93%	2,393 $321,000
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $597,821 - $760,026	-4,344 Reduced 64.03%	2,440 $374,000
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $1,055 - $1,310	-8 Reduced 0.12%	6,784 $1.1 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $228,288 - $288,851	2,125 Added 45.53%	6,792 $920,000
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $15,002 - $17,029	141 Added 3.12%	4,667 $503,000
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $58,286 - $64,934	554 Added 13.95%	4,526 $510,000
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $406,335 - $447,326	3,972 New	3,972 $430,000
Q1 2020 Apr 16, 2020	SELL	$64.5 - $97.79 $383,001 - $580,677	-5,938 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $428,307 - $535,904	5,938 New	5,938 $526,000
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $336,061 - $404,041	-5,336 Closed	0 $0
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $350,575 - $448,117	5,336 New	5,336 $388,000
Q4 2017 Jan 30, 2018	SELL	$89.56 - $98.21 $114,189 - $125,217	-1,275 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$69.85 - $89.22 $89,058 - $113,755	1,275	1,275 $113,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Account

Bristlecone Advisors, LLC Abb Vie Inc. Transaction History